Lack of effect of the ghrelin gene-derived peptide obestatin on cardiomyocyte viability and metabolism

Journal of Endocrinological Investigation

Volumn 30, Issue 6, 2007, Pages 470-476

  Iglesias, M J ^a   Salgado, A ^a   Pineiro R ^a   Rodino B K ^a   Otero, M F ^a   Grigorian, L ^a   Gallego, R ^b   Dieguez C ^b   Gualillo, O ^a   Gonzalez Juanatey J R ^a   Lago, F ^a  

^a Instituto de Salud Carlos III   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Apoptosis; Cardiomyocyte; Ghrelin; Metabolism; Obestatin

Indexed keywords

ARABINOSIDE; CYTOSINE; FATTY ACID; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 39; GHRELIN; GLUCOSE; IODINE 125; LACTATE DEHYDROGENASE; OBESTATIN; PEPTIDE HORMONE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING SITE; CELL CULTURE; CELL CYCLE; CELL METABOLISM; CELL VIABILITY; CONTROLLED STUDY; FATTY ACID METABOLISM; FATTY ACID TRANSPORT; FLOW CYTOMETRY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 34848890262     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03346330     Document Type: Article

References (27)

1. Zhang JV, Ren PG, Avsian-Kretchmer O, et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005, 310: 996-9.
2. Nogueiras R, Tschöp M. Biomedicine. Separation of conjoined hormones yields appetite rivals. Science 2005, 310: 985-6.
3. Moechars D, Depoortere I, Moreaux B, et al. Altered gastrointestinal and metabolic function in the GPR39-obestatin receptor-knockout mouse. Gastroenterology 2006, 131: 1131-41.
4. Bresciani E, Rapetti D Dona F, et al. Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat. J Endocrinol Invest 2006, 29: RC16-8
5. Nogueiras R, Pfluger P, Tovar S, et al. Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology 2006, 148: 21-6.
6. Seoane LM, Al-Massadi O, Pazos Y, Pagotto U, Casanueva FF. Central obestatin administration does not modify either spontaneous or ghrelin-incluced food intake in rats. J Endocrinol Invest 2006, 29: RC 13-5.
7. Holst B, Egerod KL, Schild E, et al. GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology 2006, 148: 13-20.
8. Holst B, Holliday ND, Bach A, Elling CE, Cox HM, Schwartz TW. Common structural basis for constitutive activity of the ghrelin receptor family. J Biol Chem 2004, 279: 53806-17.
9. Iglesias MJ, Piñeiro R, Blanco M, et al. Growth hormone releasing pepticle (ghrelin) is synthesized and secreted by cardiomyocytes. Cardiovasc Res 2004, 62: 481-8.
10. Claycomb WC, Lanson NA Jr, Stallworth BS, et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci USA 1998, 95: 2979-84.
11. Piñeiro R, Iglesias MJ, Gallego R, et al. Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Lett 2005, 579: 5163-9.
12. Munson PJ, Rodbard D. Ligand: a versatile computerized approach for characterization of ligand binding sytems. Anal Biochem 1980, 107: 220-39.
13. Gonzaláz-Juanatey JR, Iglesias MJ, Alcaide C, Piñeiro R, Lago F. Doxazosin induces apoptosis in cardiomyocytes cultured in vitro by a mechanism that is independent of alphal-adrenergic blockade. Circulation 2003, 107: 127-31.
14. Racher AJ, Looby D, Griffiths JB. Use of lactate dehydrogenase release to assess changes in culture viability. Cytotechnology 1990, 3: 301-7.
15. Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev 2005, 85: 495-522.
16. Sun Y, Ahmed S, Smith RG. Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 2003, 23: 7973-81.
17. Wortley KE, Anderson KD, Garcia K, et al. Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc Natl Acad Sci USA 2004, 101: 8227-32.
18. Cao JM, Ong H, Chen C. Effects of ghrelin and synthetic GH secretagogues on the cardiovascular system. Trends Endocrinol Metab 2006, 17: 13-8.
19. Garcia EA, Korbonits M. Ghrelin and cardiovascular health. Curr Opin Pharmacol 2006, 6: 142-7.
20. Nagaya N, Kojima M, Uetmatsu M, et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regulatory Integr Comp Physiol 2001, 280: R1483-7.
21. Nagaya N, Uematsu M, Kojima M, et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 2001, 104: 1430-5.
22. Balclanzi G, Filigheddu N, Cutrupi S, et al. Ghrelin and desacyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/ 2 and PI3-kinase/AKT. J Cell Biol 2002, 159: 1029-37.
23. Pan W, Tu H, Kastin AJ. Differential BBB interactions of three ingestive peptides:obestatin, ghrelin, and adiponectin. Peptides 2006, 27: 911-6.
24. Gualillo O, Lago F, Gómez-Reino JJ, Casanueva FF, Dieguez C. Ghrelin, a widespread hormone: insights into molecular and cellular regulation of its expression and mechanism of action. FEBS Lett 2003, 552: 105-9.
25. Sun Y, Asnicar M, Saha PK, Chan L, Smith RG. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab 2006, 3: 379-86.
26. Patel AD, Stanley SA, Murphy KG, et al. Ghrelin stimulates insulin-induced glucose uptake in adipocytes. Regul Pept 2006, 134: 17-22.
27. Lauwers E, Landuyt B, Arckens L, Schoofs L, Luyten W. Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem Biophys Res Commun 2006, 351: 21-5.